Back to User profile » Dr Noriyuki Masuda

Papers published by Dr Noriyuki Masuda:


S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma

Katono K, Sato Y, Kobayashi M, Nagashio R, Ryuge S, Igawa S, Ichinoe M, Murakumo Y, Saegusa M, Masuda N

OncoTargets and Therapy 2017, 10:5273-5279

Published Date: 2 November 2017

Long-term disease-free survivor of metastatic large-cell neuroendocrine carcinoma of the lung treated with amrubicin and irinotecan

Shinichiro Ryuge, Shi-Xu Jiang, Mayuko Wada, Ken Katono, et al.

Drug Design, Development and Therapy 2009, 3:213-217

Published Date: 13 July 2009

Next-generation anthracycline for the management of small cell lung cancer: focus on amrubicin

Michiko Yamamoto, Akira Takakura, Noriyuki Masuda

Drug Design, Development and Therapy 2008, 2:189-192

Published Date: 28 September 2008